158 related articles for article (PubMed ID: 29093427)
1. The Capsule Endoscopy Findings in S-1-induced Enteritis with Severe Diarrhea during Adjuvant Chemotherapy for Gastric Cancer (with Video).
Ota K; Takeuchi T; Kodama K; Ozaki H; Harada S; Kojima Y; Nouda S; Goto M; Higuchi K
Intern Med; 2018 Feb; 57(3):343-344. PubMed ID: 29093427
[TBL] [Abstract][Full Text] [Related]
2. Feasibility study of supportive care using lafutidine, a histamine H2 receptor antagonist, to prevent gastrointestinal toxicity during chemotherapy for gastric cancer.
Namikawa T; Munekage E; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
Anticancer Res; 2014 Dec; 34(12):7297-301. PubMed ID: 25503163
[TBL] [Abstract][Full Text] [Related]
3. Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer.
Kinoshita T; Nashimoto A; Yamamura Y; Okamura T; Sasako M; Sakamoto J; Kojima H; Hiratsuka M; Arai K; Sairenji M; Fukushima N; Kimura H; Nakajima T
Gastric Cancer; 2004; 7(2):104-9. PubMed ID: 15224197
[TBL] [Abstract][Full Text] [Related]
4. [Effect of Post-Gastrectomy Adjuvant S-1 Chemotherapy on Muscle Volume in Gastric Cancer Patients].
Iwazawa T; Kawanishi K; Fujita J; Takata A; Hirota M; Imamura H; Ikeda A; Hokonohara K; Yoneyama C; Kameyama A; Shinke G; Oshima K; Tanida T; Hatano H; Noda T; Komori T; Morita S; Akagi K; Dono K
Gan To Kagaku Ryoho; 2015 Aug; 42(8):957-60. PubMed ID: 26321709
[TBL] [Abstract][Full Text] [Related]
5. The role of S-1 in the treatment of gastric cancer.
Kubota T
Br J Cancer; 2008 Apr; 98(8):1301-4. PubMed ID: 18362933
[TBL] [Abstract][Full Text] [Related]
6. [The Case of a Patient with Gastric Cancer Who Showed No Neutropenia Only When Using the Generic S-1 Adjuvant Chemotherapy Formulation].
Shigeyoshi I; Misawa K; Ito S; Ito Y; Komori K; Abe T; Senda Y; Kinoshita T; Uemura N; Natsume S; Oshiro T; Higaki E; Shimizu Y
Gan To Kagaku Ryoho; 2018 Nov; 45(11):1653-1655. PubMed ID: 30449857
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.
Sakuramoto S; Sasako M; Yamaguchi T; Kinoshita T; Fujii M; Nashimoto A; Furukawa H; Nakajima T; Ohashi Y; Imamura H; Higashino M; Yamamura Y; Kurita A; Arai K;
N Engl J Med; 2007 Nov; 357(18):1810-20. PubMed ID: 17978289
[TBL] [Abstract][Full Text] [Related]
8. [Induction of liaison-clinical pathway for patients with gastric cancer undergoing adjuvant chemotherapy using S-1 after curative gastrectomy].
Imamura H; Anami S; Watanabe M; Kishimoto T; Miyazaki Y; Kato H; Usui T; Masutani S; Tomotsu K; Furukawa H
Gan To Kagaku Ryoho; 2008 Aug; 35(8):1361-5. PubMed ID: 18701849
[TBL] [Abstract][Full Text] [Related]
9. [Problems of adjuvant chemotherapy with S-1 for gastric cancer].
Teshima S; Saito T; Endo A; Yunome G; Harada A; Ooshio H; Kodama H; Takeda K; Kikuchi S
Gan To Kagaku Ryoho; 2010 Feb; 37(2):255-8. PubMed ID: 20154480
[TBL] [Abstract][Full Text] [Related]
10. Treatment of gastric cancer in Asia: the missing link.
Nishida T
Lancet Oncol; 2009 Nov; 10(11):1027-8. PubMed ID: 19880057
[No Abstract] [Full Text] [Related]
11. Safety, compliance, and predictive parameters for dosage modification in adjuvant S-1 chemotherapy for gastric cancer.
Kim SJ; Kim YJ; Kim JH; Park DJ; Kim HH; Lee JS; Lee KW
Cancer Sci; 2013 Jan; 104(1):116-23. PubMed ID: 23066919
[TBL] [Abstract][Full Text] [Related]
12. Safety and feasibility of adjuvant chemotherapy with S-1 for Korean patients with curatively resected advanced gastric cancer.
Jeong JH; Ryu MH; Ryoo BY; Lee SS; Park I; Lee SH; Kim KC; Yook JH; Oh ST; Kim BS; Kang YK
Cancer Chemother Pharmacol; 2012 Oct; 70(4):523-9. PubMed ID: 22864947
[TBL] [Abstract][Full Text] [Related]
13. Body weight loss after surgery is an independent risk factor for continuation of S-1 adjuvant chemotherapy for gastric cancer.
Aoyama T; Yoshikawa T; Shirai J; Hayashi T; Yamada T; Tsuchida K; Hasegawa S; Cho H; Yukawa N; Oshima T; Rino Y; Masuda M; Tsuburaya A
Ann Surg Oncol; 2013 Jun; 20(6):2000-6. PubMed ID: 23242818
[TBL] [Abstract][Full Text] [Related]
14. East meets west in the treatment of gastric cancer.
Cunningham D; Chua YJ
N Engl J Med; 2007 Nov; 357(18):1863-5. PubMed ID: 17978296
[No Abstract] [Full Text] [Related]
15. [Long survival of advanced gastric cancer patient after total gastrectomy and postoperative treatment with S-1 despite S-1+CDDP+CPT-11 causing perforation].
Imai H; Obana N; Iwabuchi T; Satou Y; Ooyauchi M; Igarashi T; Matsumoto H; Sakamoto K
Gan To Kagaku Ryoho; 2008 Jul; 35(7):1185-8. PubMed ID: 18633259
[TBL] [Abstract][Full Text] [Related]
16. [Severe bone marrow suppression during adjuvant chemotherapy for gastric cancer by S-1 and its possible relationship to dihydropyrimidine dehydrogenase deficiency].
Aragane H; Suchi K; Shimomura M; Katano T; Yasui H; Kan K
Gan To Kagaku Ryoho; 2010 Jan; 37(1):131-3. PubMed ID: 20087047
[TBL] [Abstract][Full Text] [Related]
17. [A Case of Gastric Cancer Underwent Two-Stage Gastrectomy after Chemotherapy-Induced Perforation].
Zen Y; Kaida S; Takebayashi K; Yamaguchi T; Murata S; Terada Y; Ueki T; Miyake T; Iida H; Akabori H; Kitamura N; Sonoda H; Shimizu T; Naka S; Tani M
Gan To Kagaku Ryoho; 2018 Feb; 45(2):377-379. PubMed ID: 29483453
[TBL] [Abstract][Full Text] [Related]
18. [Examination of continuity of S-1 adjuvant chemotherapy for gastric cancer patients after gastrectomy].
Kawabata R; Imamura H; Kishimoto T; Anami S; Yasui Y; Fujino M; Fujii C; Sumida R; Furukawa H
Gan To Kagaku Ryoho; 2011 May; 38(5):793-5. PubMed ID: 21566439
[TBL] [Abstract][Full Text] [Related]
19. [Postoperative adjuvant chemotherapy for gastric cancer after the adjuvant chemotherapy trial of S-1 for gastric cancer in Hiroshima prefecture: results from a questionnaire survey and future challenges].
Yamaguchi K; Hirabayashi N; Ninomiya M; Shinozaki K; Hatanaka N; Matsuda H; Tanabe K
Gan To Kagaku Ryoho; 2013 Dec; 40(13):2555-9. PubMed ID: 24335369
[TBL] [Abstract][Full Text] [Related]
20. Complete Response Obtained with S-1 Plus CDDP Therapy in a Patient with Multiple Liver Metastases from Gastric Cancer.
Nonoshita T; Otsuka S; Inagaki M; Iwagaki H
Hiroshima J Med Sci; 2015 Dec; 64(4):65-9. PubMed ID: 26964156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
